Further evidence of bradykinin involvement in septic shock: Reduction of kinin production in vivo and improved survival in rats by use of polymer tailored SBTI with longer t( 1/4 )

Immunopharmacology

Volumn 33, Issue 1-3, 1996, Pages 369-373

  Shin, Young Hee ^a,b   Akaike, Takaaki ^a   Khan, Munir Hossain ^a,c   Sakata, Yoshifumi ^a   Maeda, Hiroshi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b Kyungsung University   (South Korea)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bradykinin; hypotension; kallikrein; kallikrein kinin; polymer drug; Pseudomonas elastase; septic shock; soybean trypsin inhibitor (Kunitz)

Indexed keywords

BACTERIAL ENZYME; BRADYKININ; ELASTASE; GELATIN SUCCINATE; KININ; POLYMER; PROTEINASE; SOYBEAN TRYPSIN INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG CONJUGATION; DRUG HALF LIFE; GUINEA PIG; INTRAVENOUS DRUG ADMINISTRATION; KALLIKREIN KININ SYSTEM; MEAN ARTERIAL PRESSURE; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS; RAT; SEPTIC SHOCK; SURVIVAL;

EID: 0030175736     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/0162-3109(96)00088-4     Document Type: Conference Paper

References (19)

1. Akaike, T., M. Yoshida, Y. Miyamoto, K. Sato, M. Kohno, K. Sasamoto, K. Miyazaki, S. Ueda and H. Maeda, 1993, Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/ NO through a radical reaction. Biochemistry, 32, 827.
2. Griesbacher, T. and F. Lembeck, 1992, Effects of the bradykinin antagonist, HOE140, in experimental acute pancreatitis. Br. J. Pharmacol. 107, 356.
3. Ikenaka, T., S. Odani and T. Koide, 1974, Chemical structure and Inhibitory activities of Soybean Proteinase Inhibitors, in: Bayer-Symposium V 'Proteinase inhibitors' (Springer-Verlag), 325.
4. Kaninishi, H., M. Tanaka, T. Cho, H. Maeda and Y. Hagihara, 1990, Activation of the plasma kallikrein-kinin system by Candida albicans proteinase, Infect. Immun. 58, 2139.
5. Katori, M., M. Majima, R. Odoi-Adome, N. Sunahara and Y. Uchida, 1989, Evidence for the involvement of a kallikrein-kinin system in the immediate hypotension produced by endotoxin. Br. J. Pharmacol. 98, 1381.
6. Khan, M.M.H., T. Yamamoto, H. Araki, Y. Ijiri, Y. Shibuya, M. Okamoto and T. Kambara, 1993a, Pseudomonal elastase injection causes low vascular resistant shock in guinea pigs. Biochim. Biophys. Acta 1182, 83.
7. Khan, M.M.H., T. Yamamoto, H. Araki, Y. Shibuya and T. Kambara, 1993b, Role of Hageman factor/kallikrein-kinin systemic pseudomonal elastase induced shock model. Biochim. Biophys. Acta 1157, 119.
8. Kojima, Y., A. Haruta, T. Imai, M. Otagiri and H. Maeda, 1993, Conjugation of Cu. Zn-Superoxide dismutase with succinylated gelatin: Pharmacological activity and cell-lubricating function, Bioconjugate Chem. 4, 490.
9. Maeda, H., 1994, Polymer conjugated macromolecular drugs for tumor-specific targeting, in: Polymeric Site Specific Pharmacology. ed. A.J. Domb (John Wiley and Sons Ltd., New York). 95.
10. Maeda, H. and A. Molla, 1989, Pathogenic potentials of bacterial protease. Clin. Chim. Acta 185, 357.
11. 3] bradykinin in ascitic fluid from a patient with gastric cancer, J. Biol. Chem. 263, 16051.
12. Maeda, H., T. Akaike, Y. Sakata and K. Maruo, 1993, Role of bradykinin in microbial infection: Enhancement of septicemia by microbial proteinases and kinin, in: Agents and Actions Supplements 42, Protease, Protease Inhibitor and Protease-Derived Peptides: Importance in human pathophysiology and therapeutics. eds. J.C. Chironis and J.E. Repine. (Birkhäuser Verlag AG, Switz), 159.
13. Matsumura, Y., K. Maruo, M. Kimura, T. Yamamoto, T. Konno, and H. Maeda, 1991, Kinin-generating cascade in advanced cancer patients and in vitro study, Jpn. J. Cancer Res. 82, 732.
14. Molla, A., T. Yamamoto, T. Akaike, S. Miyoshi and H. Maeda, 1989, Activation of hageman factor and prekallikrein and generation of kinin by various microbial proteinases, J. Biol. Chem. 264, 10589.
15. Roberts, F.J., I.W. Greere and A. Coldman, 1991, A three-year study of positive blood culture, with emphasis on prognosis, Rev. Infect. Dis. 13, 34.
16. Shin, Y.H., Y. Kojima, M. Otagiri and H. Maeda, 1995, Biopharmaceutical and pharmacological properties of succinylated gelatin conjugated soybean trypsin inhibitor. Drug Delivery System (DDS) 9, 304, P13.
17. Takakura, Y., T. Fujita, M. Hashida, H. Maeda and H. Sezaki, 1989, Control of pharmaceutical properties of soybean trypsin inhibitor by conjugation with Dextranll: Biopharmaceutical and pharmacological properties. Pharm. Sci. 78, 219.
18. Werle, E., I. Trautschold, H. Haendle and H. Fritz, 1968, Physiologic, pharmacologic and clinical aspects of proteinase inhibitors. Ann. New York Acad. Sci. 146, 464.
19. Yoshida, M., T. Akaike, Y. Wada, K. Sato, K. Ikeda, S. Ueda and H. Maeda, 1994, Therapeutic effects of imidazolineoxyl N-oxide against endotoxin shock through its direct nitric oxide-scavenging activity. Biochim. Biophys. Res. Commun. 202, 923.